At a glance
- Originator Grunenthal
- Class Antiallergics; Antiasthmatics
- Mechanism of Action 5-lipoxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 24 Jan 2017 Discontinued - Preclinical for Asthma in Germany (PO)
- 05 Dec 2001 Suspended-Preclinical for Asthma in Germany (PO)
- 23 Jul 1998 No-Development-Reported for Asthma in Germany (PO)